Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation.
A 37-year-old man with acute myeloblastic leukemia (FAB M2) in first remission underwent a bone marrow transplant (BMT) following conditioning with high-dose cytarabine and total body irradiation. The donor was an HLA-identical brother. Graft rejection occurred and a second BMT was performed from the same donor following conditioning with cyclophosphamide. Engraftment was achieved, but the patient developed severe jaundice and died of respiratory failure on day +46 after the second BMT. Liver biopsy revealed luminal narrowing of the central veins and a diagnosis of hepatic veno-occlusive disease (VOD) was made. The coagulation studies showed a prolonged kaolin clotting time which was not corrected by 1:1 mixture with normal plasma, and the platelet neutralization test was positive. Dilute tissue thromboplastin time and dilute Russell viper venom time were also prolonged. These results fulfilled the criteria for lupus anticoagulant, which may have contributed to VOD in this patient.
Morio
S
S
Second Department of Internal Medicine, School of Medicine, Chiba University, Japan.
Oh
H
H
Hirasawa
A
A
Aotsuka
N
N
Nakamura
H
H
Asai
T
T
Yoshida
S
S
Ito
M
M
D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006504:Hepatic Veno-Occlusive Disease / Q000097:blood / Q000209:etiology* / Q000473:pathology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000601:surgery*; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008297:Male
D016682:Lupus Coagulation Inhibitor